Five things for pharma marketers to know: Monday, December 4, 2017
CVS to buy Aetna for $69 billion; J&J buys commercial rights for biotech’s experimental hypertension drug; Republicans repeal Obamacare’s individual mandate
Digital Health
Five things for pharma marketers to know: Friday, December 1, 2017
FDA approves first Apple Watch health accessory; medical charity shared data with pharma donors; FDA approves opioid-addiction treatment
Amazon sets its sights on healthcare
How worried should the industry’s other major players be?
How working with Apple inspired Jeff Tangney to found Doximity
The CEO’s experience launching medical reference app Epocrates led him to found a social network for physicians.
First ‘Digital Drug’ Faces a Second Litmus Test: Improving Adherence
Technology like this could expand further to form better collaborations between pharma, payers and organized providers.
Five things for pharma marketers to know: Tuesday, November 14, 2017
FDA approves first digital pill; biotech companies race to develop cancer-fighting microbiome drugs; Loxo and Bayer reach $1.55 billion deal for rare cancer drugs
AI Drug Design Could Save Lives
AI complements what we in pharma have always done best — respond to medical needs quickly and find solutions.
How Pablo Graiver plans to solve the problem of clinical-trial recruitment
The CEO and founder of Antidote talks about what inspired him to start the company, which recently received funding from Merck.
Digital Healthcare: Is It For Real?
The coming digital revolution will change a lot of things, but I guarantee this: It won’t replace the importance of the patient-physician relationship.
Why use health plan apps? To search for specialists and understand drug coverage
Consumers younger than the age of 45 were most likely to use an app developed by their health plan.
